Clinical Trials Directory

Trials / Unknown

UnknownNCT03495804

Evaluation of the Performance of Two Neutral Oral Contrast Agents in CT Enterography

Evaluation of the Performance of Two Neutral Oral Contrast Agents in CT Enterography (CTE)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

CT enterography has become an important tool in the evaluation of small bowel diseases, especially in patients with inflammatory bowel diseases. There are several shortcomings of commonly used isotonic mannitol as an oral contrast agent, such as incident adverse reactions and gases in the gut. However, polyethylene glycol can avoid these drawbacks with a good performance in some pilot experiments.

Conditions

Interventions

TypeNameDescription
DRUGpolyethylene glycolExperimental group was given polyethylene glycol as oral contrast agent.
DRUGmannitolActive comparator group was given mannitol as oral contrast agent.

Timeline

Start date
2017-11-01
Primary completion
2018-09-01
Completion
2018-10-01
First posted
2018-04-12
Last updated
2018-08-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03495804. Inclusion in this directory is not an endorsement.